| Literature DB >> 22929020 |
Michelangelo Paci1, Laura Sartiani, Martina Del Lungo, Marisa Jaconi, Alessandro Mugelli, Elisabetta Cerbai, Stefano Severi.
Abstract
BACKGROUND: Human embryonic stem cell derived cardiomyocytes (hESC-CMs) hold high potential for basic and applied cardiovascular research. The development of a reliable simulation platform able to mimic the functional properties of hESC-CMs would be of considerable value to perform preliminary test complementing in vitro experimentations.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22929020 PMCID: PMC3477113 DOI: 10.1186/1475-925X-11-61
Source DB: PubMed Journal: Biomed Eng Online ISSN: 1475-925X Impact factor: 2.819
Main developmental changes of ionic currents
| Gto (S/F) max conductance | 19.2929 | 48.702 | 294 | human, EXP, †; | |
| GKr (S/F) max conductance | 288.0 | 134.4 | 96 | rat, guinea pig, EXP, [ | |
| Gf (S/F) max conductance | 49 | 20.913 | - | human, EXP, [ | |
| GK1 (S/F) max conductance | 240.523 | 1154.508 | 5405 | human, EXP, [ | |
| GCaL (dm3/(F⋅s)) permeability | 0.0438 | 0.0739 | 0.175 | mouse, EXP, [ | |
| GCaT (S/F) max conductance | 45.8 | 9.16 | - | human, EXP, † | |
| ImaxNaCa (A/F) max current | 17500 | 18240 | 1000 | human, EXP, † | |
| GNa (S/F) max conductance | 563.844 | 14838 | 14838 | mouse, EXP, [ | |
| GKs (S/F) max conductance | 15.7 | 15.7 | 157 | human, EXP, [ | |
| ImaxNaK (A/F) max current | 0.9534 | 1.1305 | 1.362 | mouse, EXP, [ | |
| GpCa (S/F) max conductance | 0.825, § | 0.825, § | 25 | human, MOD, [ | |
| ImaxUp (mM/s) max flux | 0.0565 | 0.1403 | 0.425 | mouse, EXP, [ | |
| ImaxRel (mM/s) max flux | 0.274 | 9.88 | 24.7 | mouse, EXP, [ | |
| ImaxLeak (1/s) max rate | 0.0004 | 0.024 | 0.08 | mouse, EXP, [ | |
| GbCa (S/F) max conductance | 0.118, § | 0.592, § | 0.592 | human, MOD, [ |
Maximum conductances, currents and fluxes for Early and Late human embryonic stem cell-derived and adult ventricular cardiomyocyte models. The species considered for the Early and Late date are reported. Adult data refers to the TenTusscher model [16]. † new measurements and data; § values chosen to reproduce at best the AP shape; *2; not only the maximal conductance/current was changed but also the current formulation (see Additional file 1). EXP: experimental data; MOD: used for modelling.
Figure 1Currents: experimental data and model fitting. (A) INa inactivation for Early human embryonic stem cell-derived cardiomyocytes (hESC-CMs). (B) ICaL normalized current-voltage (I/V) curve (Late stage). (C) Cav3.1, Cav3.2 and GADPH expression (ICaT) for H1-hESC-CMs. (D) Ito I/V curves. (E) If I/V curves and HCN quantitative expression (inset). (F) INaCa elicited by a voltage ramp protocol.
Figure 2Action Potential simulations. Simulated action potentials for Early (A) and Late (B) hESC-CMs clusters.
Action potential features of experimental and simulated action potentials
| | ||||||
|---|---|---|---|---|---|---|
| APD 30 (ms) | 117 (107÷132) | 121 | 163 (84÷256) | 165 | + 40 | + 36 |
| APD 50 (ms) | 169 (149÷184) | 163 | 258 (148÷374) | 224 | + 53 | + 37 |
| APD 70 (ms) | 205 (181÷219) | 191 | 325 (179÷465) | 283 | + 59 | + 48 |
| APD 90 (ms) | 229 (216÷241) | 225 | 419 (223÷506) | 350 | + 83 | + 56 |
| Vmax (mV/s) | 4610 (3308÷5612) | 4123 | 5566 (5198÷7047) | 5620 | + 42 | + 36 |
| MDP (mV) | -55 (-62÷-37) | -76 | -51 (-62÷-42) | -73 | -7 | - 4 |
| DDR (mV/s) | 14.4 (11.1÷28.4) | 9.7 | 9.9 (8.0÷11.1) | 7.1 | - 31 | - 27 |
| F (bpm) | 27 (23÷53) | 29 | 22 (20÷29) | 24 | - 17 | - 17 |
Delta %, Late VS Early; APD, action potential duration; Vmax maximum upstroke velocity; MDP maximum diastolic potential; DDR diastolic depolarization rate; F frequency. Data reported as median and interquartile. All the experimental action potential features were measured on hESC-CM AP at the Early and Late stage [50].
Figure 3Relative sensitivity maps for the Early (A) and Late (B) models. AP features (rows) VS ratios RaIxx (columns) used to rescale the maximum conductances/currents/fluxes were considered. For each RaIxx the relative sensibilities at −20% and + 20% were taken into account. White color indicates maximum relative sensitivity of a particular AP feature among all ratios, whereas black indicates AP feature and ratio are independent. White X indicates the absence of spontaneous firing during a particular test. Percentages in each white box indicate the maximum absolute sensitivity of the AP feature correspondent to that row for all ratios. Negative sign indicates that AP feature and ratio vary inversely.
Figure 4Electrical coupling between human embryonic stem cell-derived cardiomyocyte and fibroblasts. (A, C) Effects on action potentials (APs), Early and Late stage respectively, of a variable number (Nf,) of fibroblasts. (B, D) Consequent changes of AP features, Early and Late stage respectively: both stages show an increment of the rate of spontaneous beating and an APA reduction. APD is slightly prolonged at the Early stage (especially APD70 and APD90) while at the Late stage the fibroblast effects are minor, showing only a slight reduction of APD30.
Figure 5Effects of Ryanodine. Simulation of the reduction of calcium transient amplitude under the effect of Ryanodine at Early (A) and Late (B) stages.
Figure 6Effects of current blocking with E4031 and Nickel. Single experiments (left) and simulations (right) on the effect of 10 μM E4031 (IKr blocker) and of 2 mM Nickel (INaCa, ICaT, IKr blocker) at Early (A and C) and Late (B and D) stages.